P
Prevail Therapeutics
New York, United States
Founded 2017
About
Gene therapies for neurodegenerative diseases (Eli Lilly)
Company Details
- Type
- commercial
- Employees
- 100+
- Funding
- $1B+ (acquired)
Key Products
- PR001
- PR006
- Gene Therapy
Gene therapies for neurodegenerative diseases (Eli Lilly)